Chemist with PhD and 27 years industrial experience, 21 in management including 8 as director of medicinal chemistry at Sterling Winthrop and 4 as VP of a biotech research tools company Molecular Probes. Ten years in academia, including 8 as director of MBA venture launch pathway at U of Oregon business school. Co-founder of 3 startups, including QE Chemicals.

PhD organic chemist and Associate Professor of Chemistry at the University of Oregon. Co-founder of QE Chemicals and world's expert in azaborine chemistry.

PhD organic chemist, trained in the Liu group at U of Oregon and an expert in azaborine chemistry. Ashley is creating an azaborine analog of acetaminophen, which is an object of our STTR project to prove that the analog cannot form the toxic metabolite that forms with commercial acetaminophen.

Ph.D. organic chemist, trained in the Liu group at U of Oregon, and currently serving as a post-doc in that group supporting the U of Oregon objectives of our STTR grant and responsible for cost engineering and scale-up supported by our ONAMI grant .

Co-founder and managing director of Cascade Pro-Drug; Entrepreneur in Residence for the Oregon Nanotechnologies and Microproducts Institute (ONAMI); 25 years of executive experience, including President of Molecular Probes, a catalog specialty chemicals business similar to QE.

MBA with 20 years as a CPA and CFO for a number of firms, including Spirit Leatherworks, Dune Sciences. CEO of Red Ape Cinnamon.

Former President of Microprobe, which he took public on NASDAQ. President and COO of Saigene for 10 years. Co-founder of Cascade Prodrug. Co-founder of In the Loop, LLC. Mr Cochrane is the "deal guy" in QE's corner, having completed several dozen over his entrepreneurial career.